The global genomics leader Integrated DNA Technologies (IDT) and the precision laboratory automation leader Hamilton Company announced a strategic partnership to equip researchers with a complete, efficient next-generation sequencing (NGS) solution.

This global agreement focuses on automating comprehensive genomic profiling (CGP) workflows across IDT’s broad portfolio of customizable NGS research components, specifically its xGen™ and Archer™ NGS products, by developing automation scripts for use on Hamilton's highly regarded Microlab® STAR™ and NIMBUS® liquid handling platforms.

The collaboration is designed to equip laboratories worldwide with the precision and speed necessary to accelerate important genomic discoveries, particularly in cancer research by identifying key biomarkers, while maintaining consistency and reliability. IDT President Ajay Gannerkote emphasized that by combining IDT’s flexible, modular NGS solutions with Hamilton’s automation expertise, the partnership removes the constraints of "one-size-fits-all" approaches, granting scientists the freedom to design workflows that fit their research needs, regardless of scale. Similarly, Hamilton Vice President Michael Mouradian noted that the partnership reflects a shared commitment to empowering scientists by enabling greater scalability and efficiency in genomic discoveries. Ultimately, this integration allows researchers to dedicate less time to manual processes and more time generating actionable data, bolstering IDT’s sample-to-report assay offerings and driving progress in cancer research and other genomic applications.